Emerging infections microbial threats to health in the United States
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , , |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academy Press
1992.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820336306719 |
Tabla de Contenidos:
- EMERGING INFECTIONS
- Copyright
- Preface
- Acknowledgments
- Contents
- Executive Summary
- RECOGNITION
- INTERVENTION
- The U.S. Public Health System
- Research and Training
- Vaccine and Drug Development
- VACCINES
- ANTIMICROBIAL DRUGS
- Vector Control
- Public Education and Behavioral Change
- 1 Background
- PLAGUE
- INFLUENZA
- OPTIMISM AND INDIFFERENCE
- Sanitation and Hygiene
- Quarantine
- Smallpox
- Poliomyelitis
- TROUBLE AHEAD
- Lyme Disease
- Peptic Ulcer
- Malaria
- Dengue
- Tuberculosis
- NEXT STEPS
- 2 Factors in Emergence
- THE CONCEPT OF EMERGENCE
- HUMAN DEMOGRAPHICS AND BEHAVIOR
- Population Growth, Density, and Distribution
- DENGUE
- Immunosuppression
- Sexual Activity and Substance Abuse
- TECHNOLOGY AND INDUSTRY
- Modern Medicine
- HEALTH CARE DELIVERY
- PREVENTION OF NOSOCOMIAL INFECTIONS
- Food Processing and Handling
- AGRICULTURAL CONDITIONS AND PRACTICES
- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES
- DEMOGRAPHICS
- CONSUMER ATTITUDES AND BEHAVIOR
- COMMERCE
- DIET AND FOOD PREPARATION
- Trichinosis
- Anisakiasis
- Water Treatment
- ECONOMIC DEVELOPMENT AND LAND USE
- Dam Building and Rift Valley Fever
- Reforestation and Lyme Disease
- Global Warming
- INTERNATIONAL TRAVEL AND COMMERCE
- Travel
- MALARIA
- Commerce
- HANTAAN AND RELATED HANTAVIRUSES
- THE FILOVIRUSES
- MICROBIAL ADAPTATION AND CHANGE
- Natural Variation/Mutation
- RNA VIRUSES
- Influenza A Virus
- Human Immunodeficiency Virus
- DNA VIRUSES
- Hepatitis B Virus
- BACTERIA
- Brazilian Purpuric Fever
- Selective Pressure and the Development of Resistance
- RESISTANCE TO ANTIBIOTICS
- Pneumococci
- Staphylococci and Enterococci
- Pseudomonas aeruginosa
- Mycobacterium tuberculosis
- RESISTANCE TO ANTIVIRALS
- Acyclovir and Herpes Simplex Virus.
- Zidovudine and Human Immunodeficiency Virus-1
- RESISTANCE TO ANTIMALARIALS
- VECTOR RESISTANCE TO PESTICIDES
- New Understandings: Microbes as Cofactors in Chronic Disease
- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II
- ATHEROSCLEROSIS
- HUMAN PAPILLOMAVIRUS
- BREAKDOWN OF PUBLIC HEALTH MEASURES
- Inadequate Sanitation: Cholera
- Complacency
- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES
- War
- 3 Addressing the Threats
- RECOGNITION
- Surveillance in Action: The World Health Organization's Smallpox Eradication Program
- LESSONS FROM THE SMALLPOX EXPERIENCE
- Current U.S.-Supported Surveillance Efforts
- DOMESTIC EFFORTS
- Notifiable Diseases Surveillance
- Nosocomial Infections Surveillance
- Outbreak Surveillance
- Influenza Surveillance
- Access to Surveillance Information
- INTERNATIONAL EFFORTS
- Past Successes
- Loss of Capacity
- Current Efforts
- Multilateral International Surveillance Efforts
- WORLD HEALTH ORGANIZATION
- PAN AMERICAN HEALTH ORGANIZATION
- The Concept of Global Surveillance
- INTERVENTION
- The U.S. Public Health System
- Research and Training
- THE ROCKEFELLER FOUNDATION
- NATIONAL INSTITUTES OF HEALTH
- CENTERS FOR DISEASE CONTROL
- DEPARTMENT OF DEFENSE
- OTHER PROGRAMS
- Vaccine and Drug Development
- VACCINES
- ANTIMICROBIAL DRUGS
- Vector Control
- VECTOR-CONTROL RESOURCES
- PESTICIDES FOR VECTOR CONTROL
- Public Education and Behavioral Change
- References
- Appendixes
- A Task Forces
- TASK FORCE 1
- Bacteria, Rickettsiae, and Chlamydiae
- TASK FORCE 2
- Viruses
- TASK FORCE 3
- Protozoans, Helminths, and Fungi
- TASK FORCE 4
- Policy Options
- TASK FORCE 5
- Recommendations
- B Catalog of Emerging Infectious Disease Agents
- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE
- Aeromonas
- Borrelia burgdorferi
- Campylobacter jejuni.
- Chlamydia pneumoniae (TWAR Strain)
- Chlamydia trachomatis
- Clostridium difficile
- Ehrlichia chaffeensis
- Escherichia coli O157:H7
- Haemophilus influenzae biogroup aegyptius
- Helicobacter pylori
- Legionella pneumophila
- Listeria monocytogenes
- Mycobacterium tuberculosis
- Staphylococcus aureus (and Toxic Shock Syndrome)
- Streptococcus pyogenes (Group A)
- Vibrio cholerae
- Vibrio vulnificus
- EMERGENT VIRUSES
- Bovine Spongiform Encephalopathy Agent
- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis)
- Chikungunya Virus
- Crimean-Congo Hemorrhagic Fever Virus
- Dengue Virus
- Filoviruses (Marburg, Ebola)
- Hantaviruses (Hantaan, Puumala, and Seoul)
- Hepatitis B Virus
- Hepatitis C Virus
- Hepatitis E Agent
- Human Herpesvirus-6
- Human Immunodeficiency Virus (HIV), Types 1 and 2
- Human Papillomavirus (HPV)
- Human Parvovirus B19
- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2
- Influenza A Virus
- Japanese Encephalitis Virus
- Lassa Virus
- Measles Virus
- Norwalk and Norwalk-like Agents
- Rabies Virus
- Rift Valley Fever Virus
- Ross River Virus
- Rotavirus
- Venezuelan Equine Encephalitis (VEE) Virus
- Yellow Fever Virus
- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI
- Anisakis
- Babesia
- Candida
- Crytococcus
- Cryptosporidium
- Giardia lamblia
- Microsporidia
- Plasmodium
- Pneumocystis carinii
- Strongyloides stercoralis
- Toxoplasma gondii
- C Global Resources for Infectious Disease Surveillance
- U.S. and U.S. Affiliated
- U.S. Department of Defense
- Public Health Service
- International
- World Health Organization, Geneva, Switzerland
- Pasteur Institutes
- D Committee and Staff Biographies
- COMMITTEE
- STAFF
- Glossary
- Acronyms and Abbreviations
- Index.
